Want to see SE:ARCOMA full AI Analyst Report?
Arcoma AB (ARCOMA) Stock Statistics & Valuation Metrics
Total Valuation
Arcoma AB has a market cap or net worth of SEK 121.62M. The enterprise value is SEK 73.52M.
- Market Cap
- SEK 121.62M
- Enterprise Value
- SEK 73.52M
Share Statistics
Arcoma AB has 14,308,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 14,308,510
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Arcoma AB’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 9.26%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 9.26%
- Return on Capital Employed (ROCE)
- 0.12
- Revenue Per Employee
- 4.22M
- Profits Per Employee
- 162.26K
- Employee Count
- 31
- Asset Turnover
- 1.35
- Inventory Turnover
- 5.25
Valuation Ratios
The current PE Ratio of Arcoma AB is 25.28. Arcoma AB’s PEG ratio is 4.05.
- PE Ratio
- 25.28
- PS Ratio
- 0.98
- PB Ratio
- 1.56
- Price to FCF
- 11.60
- Price to Operating Cash Flow
- 10.02
- PEG Ratio
- 4.05
Income Statement
In the last 12 months, Arcoma AB had revenue of 130.80M and earned 5.03M in profits. Earnings per share was 0.35.
- Revenue
- 130.80M
- Gross Profit
- 6.86M
- Operating Income
- 8.68M
- Pretax Income
- 6.31M
- Net Income
- 5.03M
- EBITDA
- 16.02M
- Earnings Per Share (EPS)
- 0.35
Cash Flow
In the last 12 months, operating cash flow was 12.14M and capital expenditures -1.66M, giving a free cash flow of 10.48M billion.
- Operating Cash Flow
- 12.14M
- Free Cash Flow
- 10.48M
- Free Cash Flow per Share
- 0.73
Dividends & Yields
Arcoma AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 8.62%
- Earnings Yield
- 4.01%
Stock Price Statistics
- Beta
- 0.04
- 52-Week Price Change
- 13.64%
- 50-Day Moving Average
- 7.76
- 200-Day Moving Average
- 8.14
- Relative Strength Index (RSI)
- 58.77
- Average Volume (3m)
- 9,537
Important Dates
Arcoma AB upcoming earnings date is Feb 18, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 22, 2026
- Next Earnings Date
- Feb 18, 2027
- Ex-Dividend Date
- ―
Financial Position
Arcoma AB as a current ratio of 3.49, with Debt / Equity ratio of 0.12%
- Current Ratio
- 3.49
- Quick Ratio
- 2.41
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -2.20
- Interest Coverage Ratio
- 73.58
Taxes
In the past 12 months, Arcoma AB has paid 1.28M in taxes.
- Income Tax
- 1.28M
- Effective Tax Rate
- 0.20
Enterprise Valuation
Arcoma AB EV to EBITDA ratio is 7.12, with an EV/FCF ratio of 8.71.
- EV to Sales
- 0.74
- EV to EBITDA
- 7.12
- EV to Free Cash Flow
- 8.71
- EV to Operating Cash Flow
- 7.52
Balance Sheet
Arcoma AB has SEK 30.36M in cash and marketable securities with SEK 0.00 in debt, giving a net cash position of SEK 30.36M billion.
- Cash & Marketable Securities
- SEK 30.36M
- Total Debt
- SEK 0.00
- Net Cash
- SEK 30.36M
- Net Cash Per Share
- SEK 2.12
- Tangible Book Value Per Share
- SEK 4.32
Margins
Gross margin is 4.06%, with operating margin of 5.95%, and net profit margin of 3.95%.
- Gross Margin
- 4.06%
- Operating Margin
- 5.95%
- Pretax Margin
- 4.95%
- Net Profit Margin
- 3.95%
- EBITDA Margin
- 10.38%
- EBIT Margin
- 5.95%
Analyst Forecast
The average price target for Arcoma AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -7.02%
- EPS Growth Forecast
- 6.36%
Scores
- Smart Score
- ―
- AI Score
- 63
